The recurrence of
malignant tumors is mostly caused by incompleted
surgical resection. Especially, it is difficult for surgeons to detect
and accurately remove metastatic tumors by predominantly using visual
examination and palpation owing to the lack of effective means to
specifically distinguish the boundary range between normal and tumor
tissues. Thus, the development of activated fluorescent probe with
superior tumor-to-normal (T/N) tissue ratios is particularly urgent
in clinics. In view of CD13/aminopeptidase N (APN) regarded as a cancer-specific
biomarker, mediating with progression, invasion, and migration of
malignant tumor, herein, we reported an APN-responsive fluorescent
probe YH-APN and demonstrated its application to distinguish cancer
cells. Through in situ spraying manner, fluorescent
superior tumor-to-normal (T/N) tissue ratios (subcutaneous transplantation
tumor, 13.86; hepatic metastasis, 4.42 and 6.25; splenic metastasis,
4.99) were achieved. More importantly, we have demonstrated the ability
to image metastasis tumor tissue less than 1 mm in diameter, highlighting
the potential for this probe to be used as a tool in surgical resection.
This research may spur the use of enzyme-activatable fluorescent probes
for the progress of tumor diagnosis and image-guided surgery (IGS).
DLUT) under the supervision of Prof. Xiaojun Peng in 2019. Currently,h eisworking as apostdoctoral fellow in the group of Prof. Juyoung Yoon at Ewha Womans University (EWHA). His research interest is focused on activatable fluorescent probes and photodynamic therapy.
Monitoring fluctuations in enzyme overexpression facilitates early tumor detection and excision. An AIEgen probe (DQM‐ALP) for the imaging of alkaline phosphatase (ALP) activity was synthesized. The probe consists of a quinoline‐malononitrile (QM) core decorated with hydrophilic phosphate groups as ALP‐recognition units. The rapid liberation of DQM‐OH aggregates in the presence of ALP resulted in aggregation‐induced fluorescence. The up‐regulation of ALP expression in tumor cells was imaged using DQM‐ALP. The probe permeated into 3D cervical and liver tumor spheroids for imaging spatially heterogeneous ALP activity with high spatial resolution on a two‐photon microscopy platform, providing the fluorescence‐guided recognition of sub‐millimeter tumorigenesis. DQM‐ALP enabled differentiation between tumor and normal tissue ex vivo and in vivo, suggesting that the probe may serve as a powerful tool to assist surgeons during tumor resection.
Haidong Li obtained his Ph.D. from Dalian University of Technology (DLUT) under the supervision of Prof. Xiaojun Peng in 2019. Currently,h eisworking as apostdoctoral fellow in the group of Prof. Juyoung Yoon at Ewha Womans University (EWHA). His research interest is focused on activatable fluorescent probes and photodynamic therapy.
The
treatment of diseases caused by drug-resistant bacterial infections
urgently requires new types of broad-spectrum antimicrobial materials.
Herein, we introduce a supramolecular self-assembly, NanoPcN, which
realizes the combination of type I photodynamic activity and photothermal
effects by modifying zinc(II) phthalocyanine with a 3-(dimethylamino)
phenoxy group. Antibacterial experiments demonstrate that this “one-for-two”
property endows NanoPcN with excellent antimicrobial efficacy, not
only against Gram-positive and Gram-negative bacteria but also against
multidrug-resistant bacteria. An ultralow concentration of NanoPcN
(50 nM) almost completely inhibited the growth of methicillin-resistant Staphylococcus aureus upon 655 nm laser irradiation
(0.5 W/cm2) for 2 min, and the antibacterial effect was
significantly stronger than that of the known photosensitizers methylene
blue and tetraphenylporphyrin tetrasulfonic acid. Thus, the construction
of “one-for-two” materials through a simple molecular
structure modification paves a feasible way for the development of
effective broad-spectrum antibacterial agents.
A novel multifunctional aminophenylboronic acid connected to a diphenylketone gives both circular dichroism and fluorescence signals by in situ generation of a BODIPY-like chromophore in the presence of aminoalcohols. DFT calculations were used to understand the role of each functional group in the mechanism. This new sensor can distinguish different aminoalcohols and quantitatively indicate the concentration of the substrate, allowing for the convenient determination of the ee of racemic mixtures with a single probe.
Increasingly infectious diseases of microbial pathogens (including bacteria and fungi) threaten human health a situation that has aroused public health concern around the world. Unfortunately, broad-spectrum antimicrobial agents of non-treatment resistance to date and molecular research on their antimicrobial mechanism are still scarce. Thus, the development of smart agents against microbial infection for surmounting the above dilemmas is an urgent task. In this contribution, we have tactfully designed a family of flexible AIEgens with various alkyl chain lengths and successfully optimized a cationic AIEgen TPA-S-C6-NMe 3 + based on the molecular relay strategy (MRS) for killing both bacteria and fungi in vitro with desired results under white light irradiation, superior to traditional commercial photosensitizers including methylene blue, chlorin e6, and protoporphyrin IX. The cationic AIEgens TPA-S-C6-NMe 3 + were bound to microbial pathogens via electrostatic and hydrophobic forces and exerted antimicrobial pathogens efficacy by virtue of the synergistic effect of alkyl chain length, reactive oxygen species (ROS) generation capability, and double-positive charges.Remarkably, AIEgen TPA-S-C6-NMe 3 + also exhibited a striking antimicrobial activity in vivo, and promoted the
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.